Researchers developed bispecific heterodimer radiotracers, like 68Ga-FAPI-RGD and 68Ga/18F-labeled FAPI-PSMA, demonstrating high tumor uptake and favorable in vivo pharmacokinetics (Wang et al.2023; Zang et al.2022). The gene discussed is FOLH1; the disease is neoplasm.